Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDERYTECH Pharma S.A. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2022 | Q4 2022 | N/A | $0.19 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.17 | N/A | N/A | $0 |
| 09/12/2022 | Q2 2022 | N/A | $0.35 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 04/27/2022 | Q4 2021 | N/A | -$0.49 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | $0.00 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.74 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.55 | N/A | N/A | $0 |
| 03/08/2021 | Q4 2020 | -$0.90 | -$1.10 | -0.2 | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$1.04 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.97 | N/A | N/A | $924,500 |
| 03/30/2020 | Q1 2020 | N/A | -$0.98 | N/A | N/A | $0 |
| 03/18/2020 | Q4 2019 | -$0.86 | -$1.08 | -0.22 | N/A | $3.36 M |
| 09/29/2019 | Q3 2019 | N/A | -$0.78 | N/A | N/A | $0 |
| 06/29/2019 | Q2 2019 | N/A | -$0.98 | N/A | N/A | $0 |
| 03/30/2019 | Q1 2019 | N/A | -$0.65 | N/A | N/A | $0 |
| 03/29/2019 | Q4 2018 | N/A | -$0.48 | N/A | N/A | $0 |
| 09/29/2018 | Q3 2018 | N/A | -$0.60 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ERYTECH Pharma S.A. Earnings: FAQ's
ERYTECH Pharma S.A. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 26th, 2023 based offlast year's report dates.
In the previous quarter, ERYTECH Pharma S.A. (:ERYP) reported $-0.35694 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.07306.
The conference call for ERYTECH Pharma S.A.'s latest earnings report can be listened to online.
The conference call transcript for ERYTECH Pharma S.A.'s latest earnings report can be read online.
ERYTECH Pharma S.A. (:ERYP) has a recorded net income of $-228,000.ERYTECH Pharma S.A. has generated $-0.0074 earnings per share over the last four quarters.
ERYTECH Pharma S.A. (:ERYP) has a price-to-earnings ratio of -0.18 and price/earnings-to-growth ratio is -0.01.